These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27015536)

  • 1. Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.
    Coleman MA; Cappuccio JA; Blanchette CD; Gao T; Arroyo ES; Hinz AK; Bourguet FA; Segelke B; Hoeprich PD; Huser T; Laurence TA; Motin VL; Chromy BA
    PLoS One; 2016; 11(3):e0150166. PubMed ID: 27015536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state.
    Raab R; Swietnicki W
    Protein Expr Purif; 2008 Mar; 58(1):53-60. PubMed ID: 18160307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein.
    Ryndak MB; Chung H; London E; Bliska JB
    Infect Immun; 2005 Apr; 73(4):2433-43. PubMed ID: 15784589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Yersinia Translocon Pore Formation in Erythrocytes.
    Costa TRD; Francis MK; Farag SI; Edgren T; Francis MS
    Methods Mol Biol; 2019; 2010():211-229. PubMed ID: 31177441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of Yops.
    Williams AW; Straley SC
    J Bacteriol; 1998 Jan; 180(2):350-8. PubMed ID: 9440524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Jan; 31(1):143-56. PubMed ID: 9987117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
    Kwuan L; Adams W; Auerbuch V
    Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
    Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
    Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocators YopB and YopD from Yersinia enterocolitica form a multimeric integral membrane complex in eukaryotic cell membranes.
    Montagner C; Arquint C; Cornelis GR
    J Bacteriol; 2011 Dec; 193(24):6923-8. PubMed ID: 22001511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live imaging of Yersinia translocon formation and immune recognition in host cells.
    Rudolph M; Carsten A; Kulnik S; Aepfelbacher M; Wolters M
    PLoS Pathog; 2022 May; 18(5):e1010251. PubMed ID: 35604950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Sep; 33(5):971-81. PubMed ID: 10476031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.
    Mueller CA; Broz P; Müller SA; Ringler P; Erne-Brand F; Sorg I; Kuhn M; Engel A; Cornelis GR
    Science; 2005 Oct; 310(5748):674-6. PubMed ID: 16254184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.